Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
5-Chloro-2-(piperidin-4-yloxy)pyridine → 5-[({4-[(5-Chloropyridin-2-yl)oxy]piperidin-1-yl}sulfonyl)methyl]-5-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]imidazolidine-2,4-dione
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 5-Chloro-2-(piperidin-4-yloxy)pyridine | HCID 11264329 | — |
| 반응물 | Racemic {2,5-dioxo-4-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]imidazolidin-4-yl}methanesulfonyl chloride | HCID 23133523 | — |
| 생성물 | 5-[({4-[(5-Chloropyridin-2-yl)oxy]piperidin-1-yl}sulfonyl)methyl]-5-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]imidazolidine-2,4-dione | HCID 23133491 | — |
반응 단계
The title compound was prepared as described in Example 12 from racemic {2,5-dioxo-4-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]imidazolidin-4-yl}methanesulfonyl chloride and 5-chloro-2-(piperidin-4-yloxy)-pyridine.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07427631B2 |
| 출처 데이터셋 | uspto-grants-2008_09 |
| ORD ID | ord-2c292d5db70444ad8630d8c141ce7b99 |
| 출처 메모 | uspto-grants-2008_09 |